aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.853
+0.029 (3.47%)
Mar 9, 2026, 3:05 PM EDT - Market open
aTyr Pharma Analyst Ratings
Total Analysts
8
Consensus Rating
Hold
Price Target
$4.20
Upside
+392.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +17.29% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $25 → $1 | Buy → Hold | Downgrades | $25 → $1 | +17.29% | Sep 16, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $16 → $1.5 | Buy → Hold | Downgrades | $16 → $1.5 | +75.93% | Sep 16, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $1 | Buy → Hold | Downgrades | $1 | +17.29% | Sep 15, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 15, 2025 |
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy → Hold Downgrades $11 → $1 | Strong Buy → Hold | Downgrades | $11 → $1 | +17.29% | Sep 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 15, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $9 → $17 | Strong Buy | Maintains | $9 → $17 | +1,893.90% | Aug 22, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $25 | Buy | Maintains | $17 → $25 | +2,832.21% | Jun 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +4,005.09% | Jun 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +4,005.09% | May 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +4,005.09% | Mar 14, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +1,776.61% | Feb 18, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +4,005.09% | Dec 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.